 really take care of all the symptoms that patients had or take care of it completely. But with Avakit, we now have a treatment option that targets the genetic underlying pain that drives the systemic mastocytosis. And what it does is it improves symptoms for the patients, which is what we all are trying to do in this condition. Absolutely. Suki, how have you been feeling?